Stimulating a patient's defences to recognize and eliminate cancer cells holds immense promise for many malignancies.
Immunotherapy obviates the need for often toxic chemotherapy in sensitive populations like infants or older adults and increases the chance of cures in specific selected populations.
Immunotherapy has shown remarkable results for a subset of colorectal cancer patients. Read to know who is the ideal candidate for immunotherapy.
Understanding how ovarian cancer cells hide from the body's immune system will help in developing more effective immunotherapies, say researchers.
Scientists at Yale University have made a breakthrough discovery that might pave the way for effective cancer vaccines.
Dinutuximab is approved by The U.S. Food and Drug Administration (FDA) and is used for those patients whose condition hasn't improved after the standard cancer treatment.
Cancer patients receiving immune checkpoint inhibitors may developed skin problems like itching, inflammation, rash, skin colour loss, swelling or blisters. But clinicians should avoid prescribing corticosteroids to treat these skin problems. Researchers explain why?
A University of Missouri researcher has found a new way to help the body's immune system destroy cancer, with the help of a more than 50-year-old strain of bacteria.
In a study, use of vitamin D supplements was linked to 54 percent lower odds of developing colitis in patients receiving immune checkpoint inhibitors to treat cancer.
According to recent study, immunotherapy may be a lifesaver for patients of prostate cancer. Read on to know more.
Researchers have now discovered that a combination of immune checkpoint blockade and targeted therapies that block normal DNA damage repair (DDR) achieved significant tumour regression in mouse models of small cell lung cancer (SCLC).
Italian oncologists have taken a major stride in defeating cancer, as they came up with a medicine which is really close to beat tumours and make our bodies better able to fight them.
Stimulating a patient's defences to recognize and eliminate cancer cells holds immense promise for many malignancies.
Immunotherapy obviates the need for often toxic chemotherapy in sensitive populations like infants or older adults and increases the chance of cures in specific selected populations.
Immunotherapy has shown remarkable results for a subset of colorectal cancer patients. Read to know who is the ideal candidate for immunotherapy.
Understanding how ovarian cancer cells hide from the body's immune system will help in developing more effective immunotherapies, say researchers.
Scientists at Yale University have made a breakthrough discovery that might pave the way for effective cancer vaccines.
Dinutuximab is approved by The U.S. Food and Drug Administration (FDA) and is used for those patients whose condition hasn't improved after the standard cancer treatment.
Cancer patients receiving immune checkpoint inhibitors may developed skin problems like itching, inflammation, rash, skin colour loss, swelling or blisters. But clinicians should avoid prescribing corticosteroids to treat these skin problems. Researchers explain why?
A University of Missouri researcher has found a new way to help the body's immune system destroy cancer, with the help of a more than 50-year-old strain of bacteria.
In a study, use of vitamin D supplements was linked to 54 percent lower odds of developing colitis in patients receiving immune checkpoint inhibitors to treat cancer.
According to recent study, immunotherapy may be a lifesaver for patients of prostate cancer. Read on to know more.
Researchers have now discovered that a combination of immune checkpoint blockade and targeted therapies that block normal DNA damage repair (DDR) achieved significant tumour regression in mouse models of small cell lung cancer (SCLC).
Italian oncologists have taken a major stride in defeating cancer, as they came up with a medicine which is really close to beat tumours and make our bodies better able to fight them.
